Synopsis
Synopsis
0
KDMF
0
VMF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cefalotin
2. Cefalotina Normon
3. Cefalotina Sodica Spaly
4. Ceftina
5. Cephalothin
6. Cephalothin Monosodium Salt
7. Cephalothin, Sodium
8. Keflin
9. Monosodium Salt, Cephalothin
10. Salt, Cephalothin Monosodium
11. Seffin
12. Sodium Cephalothin
1. Cefalotin Sodium
2. 58-71-9
3. Sodium Cephalothin
4. Cephalothin Sodium Salt
5. Seffin
6. Keflin
7. Sodium Cefalotin
8. Sodium Cephalotin
9. Cefalotina Sodica
10. Cefalotin Sodium Salt
11. Cephalothin (sodium)
12. Sodium (6r,7r)-3-(acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
13. C22g6eyp8b
14. 7-(thiophene-2-acetamido)cephalosporanic Acid Sodium Salt
15. Chebi:3542
16. Nsc-756667
17. Monosodium (6r,7r)-3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate Acetate (ester)
18. Cefalothine
19. Toricelocin
20. Ceporacin
21. Cepovenin
22. Lospoven
23. Microtin
24. Synclotin
25. Cet Injektionsfl
26. Tokiosarl Ampullen
27. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, Monosodium Salt, (6r-trans)-
28. Keflin In Plastic Container
29. Lovvalline Injektionsfl
30. Mls000069577
31. Lilly 38253
32. Cephalothin Sodium [usan]
33. Keflin N Injektionsflaschen
34. Cefalotina Sodica [spanish]
35. Smr000058777
36. Einecs 200-394-6
37. Unii-c22g6eyp8b
38. Cephalothin Sodium W/ Dextrose In Plastic Container
39. Cephalothin Sodium [usan:usp]
40. Cephalothin Sodium W/ Sodium Chloride In Plastic Container
41. Sodium (6r,7r)-3-(acetoxymethyl)-8-oxo-7-((2-thienylacetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
42. Sodium (6r,7r)-3-(acetoxymethyl)-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
43. Prestwick_971
44. Keflin (tn)
45. Mfcd00072025
46. 7-(2-thienylacetamido)cephalosporanic Acid Sodium Salt
47. Sodium;(6r,7r)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
48. Cephalothin Sodium (usp)
49. Cefalotin Sodium (jp17)
50. Cefalothin Sodium Salt,(s)
51. Chembl1632
52. Schembl148785
53. Spectrum1500166
54. Cefalotin Sodium [jan]
55. Hms500e19
56. Cefalotin Sodium [mart.]
57. Dtxsid30891362
58. Cefalotin Sodium [who-dd]
59. Cephalothin Sodium [vandf]
60. Hms1570o19
61. Hms1920k11
62. Hms2091a14
63. Hms2097o19
64. Hms3260j08
65. Hms3714o19
66. Hy-b1275
67. Cephalothin Sodium, Cefalotin Sodium
68. Tox21_500283
69. Ccg-38923
70. Cephalothin Sodium Salt [mi]
71. S4594
72. Akos015896088
73. Cefalotin Sodium [ep Impurity]
74. Cefalotin For Impurity B Identification
75. Cefalotin Sodium [ep Monograph]
76. Cs-4850
77. Ks-1135
78. Lp00283
79. Nsc 756667
80. Cephalothin Sodium [orange Book]
81. Cephalothin Sodium [usp Impurity]
82. Ncgc00093737-01
83. Ncgc00260968-01
84. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, Monosodium Salt, (6r,7r)-
85. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, Acetate, Monosodium Salt
86. Ac-15529
87. Cephalothin Sodium [usp Monograph]
88. Cephalothin Sodium Salt, 96.0-101.0%
89. Eu-0100283
90. C 4520
91. C-2720
92. C08100
93. D00907
94. Q27106126
95. 7-(thiophene-2-acetamido)cephalosporanic Acid Sodium
96. Cephalothin Sodium Salt, Bioreagent, Suitable For Cell Culture
97. Cephalotin Sodium Salt, Antibiotic For Culture Media Use Only
98. Cefalotin Sodium, European Pharmacopoeia (ep) Reference Standard
99. Cephalothin Sodium, United States Pharmacopeia (usp) Reference Standard
100. Sodium 7beta-(2-thienylacetamido)-3-acetoxymethyl-3-cephem-4-carboxylate
101. Cefalotin For Impurity B Identification, European Pharmacopoeia (ep) Reference Standard
102. Sodium (6r, 7r)-3-acetoxymethyl-7-(thien-2-ylacetamido)ceph-3-em-4-carboxylate
103. Sodium (6r,7r)-3-acetoxymethyl-7-(thien-2-ylacetamido)ceph-3-em-4-carboxylate
104. (6r,7r)-3-acetoxymethyl-8-oxo-7-(2-thiophen-2-yl-acetylamino)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate Sodium
105. Monosodium (6r,7r)-3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate Acetate
106. Sodium (6r,7r)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
107. Sodium (6r,7r)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Molecular Weight | 418.4 g/mol |
---|---|
Molecular Formula | C16H15N2NaO6S2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 7 |
Exact Mass | 418.02692283 g/mol |
Monoisotopic Mass | 418.02692283 g/mol |
Topological Polar Surface Area | 169 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 686 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
67
PharmaCompass offers a list of Cefalotin sodium Sterile API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefalotin sodium Sterile manufacturer or Cefalotin sodium Sterile supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefalotin sodium Sterile manufacturer or Cefalotin sodium Sterile supplier.
PharmaCompass also assists you with knowing the Cefalotin sodium Sterile API Price utilized in the formulation of products. Cefalotin sodium Sterile API Price is not always fixed or binding as the Cefalotin sodium Sterile Price is obtained through a variety of data sources. The Cefalotin sodium Sterile Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cephalothin Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cephalothin Sodium, including repackagers and relabelers. The FDA regulates Cephalothin Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cephalothin Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cephalothin Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cephalothin Sodium supplier is an individual or a company that provides Cephalothin Sodium active pharmaceutical ingredient (API) or Cephalothin Sodium finished formulations upon request. The Cephalothin Sodium suppliers may include Cephalothin Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Cephalothin Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cephalothin Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Cephalothin Sodium active pharmaceutical ingredient (API) in detail. Different forms of Cephalothin Sodium DMFs exist exist since differing nations have different regulations, such as Cephalothin Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cephalothin Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Cephalothin Sodium USDMF includes data on Cephalothin Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cephalothin Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cephalothin Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cephalothin Sodium Drug Master File in Japan (Cephalothin Sodium JDMF) empowers Cephalothin Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cephalothin Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Cephalothin Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cephalothin Sodium suppliers with JDMF on PharmaCompass.
A Cephalothin Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Cephalothin Sodium Certificate of Suitability (COS). The purpose of a Cephalothin Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cephalothin Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cephalothin Sodium to their clients by showing that a Cephalothin Sodium CEP has been issued for it. The manufacturer submits a Cephalothin Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cephalothin Sodium CEP holder for the record. Additionally, the data presented in the Cephalothin Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cephalothin Sodium DMF.
A Cephalothin Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cephalothin Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cephalothin Sodium suppliers with CEP (COS) on PharmaCompass.
A Cephalothin Sodium written confirmation (Cephalothin Sodium WC) is an official document issued by a regulatory agency to a Cephalothin Sodium manufacturer, verifying that the manufacturing facility of a Cephalothin Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cephalothin Sodium APIs or Cephalothin Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Cephalothin Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Cephalothin Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cephalothin Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cephalothin Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cephalothin Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cephalothin Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cephalothin Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cephalothin Sodium suppliers with NDC on PharmaCompass.
Cephalothin Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cephalothin Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cephalothin Sodium GMP manufacturer or Cephalothin Sodium GMP API supplier for your needs.
A Cephalothin Sodium CoA (Certificate of Analysis) is a formal document that attests to Cephalothin Sodium's compliance with Cephalothin Sodium specifications and serves as a tool for batch-level quality control.
Cephalothin Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Cephalothin Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cephalothin Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Cephalothin Sodium EP), Cephalothin Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cephalothin Sodium USP).